Dyshidrotic eczema, also known as pompholyx, is a type of eczema that causes small, itchy blisters to form on the palms of the hands and the sides of the fingers. It can also affect the soles of the feet. It is a chronic condition that can cause significant discomfort and distress. Fortunately, there are a number of treatments and strategies that can help to manage the symptoms of dyshidrotic eczema. In this article, we will look at some of the ways that doctors can help their patients to manage this condition.
Dyshidrotic eczema is a type of eczema that affects the palms of the hands and the sides of the fingers. It is characterized by the formation of small, itchy blisters that can be painful and cause significant discomfort. The blisters typically last for around three weeks before they heal, but they may recur periodically. Dyshidrotic eczema is a chronic condition that can last for months or even years. It is more common in women than in men, and it typically affects people between the ages of 20 and 40.
The exact cause of dyshidrotic eczema is not known, but there are a number of factors that may contribute to its development. These include stress, allergies, or contact with certain substances such as nickel or cobalt. It is also thought that people with certain genetic predispositions may be more likely to develop the condition.
Dyshidrotic eczema can be diagnosed by a doctor based on the symptoms and a physical examination. In some cases, a skin biopsy may be necessary to confirm the diagnosis. The doctor may also perform tests to rule out other conditions that may cause similar symptoms.
Treatment of dyshidrotic eczema typically involves a combination of topical and oral medications. Topical medications, such as corticosteroids, can help to reduce inflammation and itching. Oral medications, such as antihistamines, can also help to reduce itching and inflammation. In some cases, phototherapy may be recommended to help reduce inflammation and itching.
In addition to medications, lifestyle changes can also help to manage the symptoms of dyshidrotic eczema. These include avoiding triggers such as stress, certain foods, and contact with certain substances. Wearing gloves when doing activities such as gardening or cleaning can also help to protect the hands from further irritation. Keeping the hands and feet moisturized can also help to reduce itching and discomfort.
Dyshidrotic eczema is a chronic condition that can cause significant discomfort and distress. Fortunately, there are a number of treatments and strategies that can help to manage the symptoms. Doctors can help their patients to manage the condition by prescribing medications and recommending lifestyle changes. With the right treatment and care, patients can find relief from the symptoms of dyshidrotic eczema.
1.
Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Top 10 questions about breast cancer answered
4.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
5.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
1.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
2.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
3.
The Growing Crisis of Aplastic Anemia: A Call for Action
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation